BioSpace News Archive

Receives $36 million of funding in Series A to fuel growth and innovation in lab development

The world’s most innovative medical aesthetic leaders will join together on March 26-29th at the Four Seasons Beverly Hills to share the latest discoveries, trends, and techniques shaping the industry

MDsave, the world’s first online marketplace providing patients the ability to shop, compare and instantly purchase their healthcare services, today announced the appointment of Greg Born as company president and chief operating officer

Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today again confirmed efforts to evaluate its proprietary CBD extract formulation as a treatment for coronavirus symptoms. KALY’s proprietary CBD formulation has been developed for the treatment of symptoms associated with Chronic Obstructive Pulmonary Disease (COPD) and other similar respiratory conditions.

Prodigo Solutions and their community of leading healthcare providers are proud to announce that we have a new way of communicating your product content with Prodigo’s Global Catalog.

Dr. Adrian R. Krainer, pioneer in neuromuscular disease treatment to be honored at June 8 symposium in New York City

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent success story that examines how marketing mix modeling study for a leading US pharma company resulted in better marketing ROI

Today, Trifecta Clinical, the industry leader in process automation for clinical trial training and site communication, announced that all training certification fees will be waived for pharmaceutical companies sponsoring clinical trials for COVID-19 (coronavirus).

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), today announced that its Chief Executive Officer (“CEO”), Mr. Seth M. Shaw, will deliver the presentation on Cannabis Investments at the NY TradersEXPO (“MoneyShow”) on March 9, 2020 at 9:00am EST.

As part of the biopharmaceutical industry’s commitment to advance diversity and inclusion in the workplace, president and chief executive officer Stephen J. Ubl of the Pharmaceutical Research and Manufacturers of America signed the CEO Action for Diversity & Inclusion Pledge.